{"id":"CHEMBL1198500","canonicalSmiles":"N[C@H](CC1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"JGFCNVHEEMBVJG-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198500","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07190"]},"childChemblIds":["CHEMBL606184"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200495","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+]","inchiKey":"HHZQLQREDATOBM-CODXZCKSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE SODIUM SUCCINATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL977","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A-hydrocort","Hcss","Hydrocortisone sodium succinate","Solu-cortef"],"synonyms":["Cortisol 21-(sodium succinate)","Hydrocortisone 21-sodium succinate","Hydrocortisone sodium succinate","Hydrocortisoni natrii succinas","NSC-9152","SOLU-CORTEF"],"crossReferences":{"DailyMed":["hydrocortisone%20sodium%20succinate"],"PubChem":["144207050","170465053","50106430","855547"],"chEBI":["5782"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0006834","EFO_0000220","EFO_0000403","MONDO_0000870","HP_0004798","EFO_0000565","EFO_0000309","EFO_0003032","EFO_1001936","EFO_1001947","MONDO_0004979","EFO_0009552","MONDO_0020743","EFO_0005752"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL1200673","canonicalSmiles":"[127Xe]","inchiKey":"FHNFHKCVQCLJFQ-AHCXROLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XENON XE 127","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1236802","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xenon xe 127"],"synonyms":["127xe","Xenon (127Xe) Gas","Xenon (127xe)","Xenon (127xe) gas","Xenon 127","Xenon xe 127","Xenon xe-127","Xenon, xe-127","Xenon-127"],"crossReferences":{"drugbank":["DB09461"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200710","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl","inchiKey":"WIMWMKZEIBHDTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOMIPRAMINE HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL415","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anafranil","Anafranil sr","Chlorimipramine","Clomipramine hydrochloride","Tranquax"],"synonyms":["Clomipramine hcl","Clomipramine hydrochloride","G 34586","G-34586","NSC-759323"],"crossReferences":{"DailyMed":["clomipramine%20hydrochloride"],"PubChem":["144212136","26747483","50106071","56422907","855785"],"chEBI":["3755"]},"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0004242"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for obsessive-compulsive disorder and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200906","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.[Br-]","inchiKey":"UKLQXHUGTKWPSR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENONIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201286","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antrenyl"],"synonyms":["Antrenil","BA-5473","C-5473","NSC-759248","Oxifenon","Oxyfenon","Oxyphenon","Oxyphenonium bromide","Spasmodin","Spasmophen"],"crossReferences":{"PubChem":["144204402","170465282","56422900","855750"],"Wikipedia":["Oxyphenonium_bromide"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200929","canonicalSmiles":"O=S(=O)([O-])[O-].[Zn+2]","inchiKey":"NWONKYPBYAMBJT-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC SULFATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pennine","Sootheye","White Vitriol","Z Span","Zinc sulfate","Zincfrin","Zincomed","Zincosol","Zindole","Zing","Zn sulf co"],"synonyms":["NSC-135806","NSC-32677","Sulfuric acid, zinc salt (1:1)","Zinc (as sulfate)","Zinc (as sulphate)","Zinc sulfate","Zinc sulfate (1:1) monohydrate","Zinc sulfate (anhydrous)","Zinc sulfate anhydrous","Zinc sulfate hydrate","Zinc sulfate monohydrate","Zinc sulfate, anhydrous","Zinc sulfate, unspecified","Zinc sulfate, unspecified form","Zinc sulphate","Zinc sulphate (1:1) monohydrate","Zinc sulphate anhydrous","Zinc sulphate hydrate","Zinc sulphate, anhydrous","Zinci sulfas monohydrate"],"crossReferences":{"DailyMed":["zinc%20sulfate"],"DrugCentral":["4275"],"Wikipedia":["Zinc_sulfate"],"drugbank":["DB09322"],"chEBI":["35176"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL1201027","canonicalSmiles":"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-]","inchiKey":"VPNYRYCIDCJBOM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOPYRROLATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201335","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cuvposa","Glycopyrrolate","Glyrx-pf","Lonhala magnair kit","Robinul","Robinul forte","Robinul fte","Seebri","Sialanar"],"synonyms":["AD-237","AHR-504","CHF-5259","CHF5259","Glycopyrrolate","Glycopyrrolate, erythro-","Glycopyrrone bromide","Glycopyrronium (as bromide)","Glycopyrronium bromide","NSC-250836","NSC-251251","NSC-251252","NVA-237","NVA237","Nodapton","ORG-NC-45","PT-001","PT001","Robanul","Tarodyl","Tarodyn"],"crossReferences":{"DailyMed":["glycopyrrolate"],"PubChem":["144206695","144206696","170465427","85273808"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004210","EFO_0009512","EFO_0001645","EFO_0009516","MONDO_0001187","EFO_0007149","HP_0006536","MONDO_0002050","EFO_0010282","HP_0000975","MONDO_0004979","EFO_0000341","HP_0002307","GO_0007596","EFO_0005251"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for gastrointestinal disease and airway obstruction and has 7 investigational indications."}
{"id":"CHEMBL1201032","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O=C(O)c1ccccc1","inchiKey":"JPRXYLQNJJVCMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIZATRIPTAN BENZOATE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL905","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxalt","Maxalt-mlt","Rizatriptan benzoate"],"synonyms":["MK-0462","NSC-758919","Rizatriptan benzoate"],"crossReferences":{"DailyMed":["rizatriptan%20benzoate"]},"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0100431","MONDO_0005277","MONDO_0005475"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL1201219","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1","inchiKey":"BGSZAXLLHYERSY-XQIGCQGXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VECURONIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vecuronium","Vecuronium cation","Vecuronium ion"],"crossReferences":{"DailyMed":["vecuronium%20bromide"],"PubChem":["50112721"],"Wikipedia":["Vecuronium_bromide"],"drugbank":["DB01339"],"chEBI":["9939"]},"childChemblIds":["CHEMBL1200629"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["MONDO_0018373","EFO_0004210","HP_0003040","EFO_0005323","MONDO_0043510","MONDO_0005178","EFO_0004337","EFO_1001250"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201313","canonicalSmiles":"CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl","inchiKey":"WRCHFMBCVFFYEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOPHEDIANOL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Antitussin","Chlophedianol","Clofedanol","NSC-113595","Tussistop"],"crossReferences":{"PubChem":["144206265","93577132"],"Wikipedia":["Clofedanol"],"drugbank":["DB04837"]},"childChemblIds":["CHEMBL1200972"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cough."}
{"id":"CHEMBL1201342","canonicalSmiles":"CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1","inchiKey":"MJFJKKXQDNNUJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIXENE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Atosil","Methixene","Metixene"],"crossReferences":{"Wikipedia":["Metixene"],"drugbank":["DB00340"],"chEBI":["51024"]},"childChemblIds":["CHEMBL2359044","CHEMBL1200426"],"linkedTargets":{"rows":["ENSG00000168539","ENSG00000147246"],"count":2},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for parkinson disease."}
{"id":"CHEMBL1201587","drugType":"Antibody","blackBoxWarning":true,"name":"ALEMTUZUMAB","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Campath","Campath Mabcampath, Lemtrada","Campath mabcampath","Lemtrada","Mabcampath"],"synonyms":["Alemtuzumab","Alemtuzumab (genetical recombination)","CAMPATH-1H","GZ-402673","GZ402673","LDP-03"],"crossReferences":{"DailyMed":["alemtuzumab"],"DrugCentral":["4909"],"Wikipedia":["Alemtuzumab"]},"linkedTargets":{"rows":["ENSG00000169442"],"count":1},"linkedDiseases":{"rows":["EFO_1001257","Orphanet_183660","EFO_0007323","Orphanet_848","EFO_0005952","EFO_0000540","EFO_0000565","EFO_0006803","EFO_0007160","EFO_0003884","MONDO_0015540","EFO_0000094","EFO_1000785","EFO_0000400","Orphanet_379","EFO_0000198","MONDO_0013730","EFO_0009441","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_1001946","MONDO_0044881","EFO_0000384","MONDO_0009453","MONDO_0044889","MONDO_0001023","MONDO_0021193","MONDO_0019472","EFO_0002428","EFO_0000574","EFO_1001051","EFO_0001378","Orphanet_84","EFO_0003086","Orphanet_232","EFO_0000255","EFO_0000209","HP_0001915","MONDO_0002087","MONDO_0003541","EFO_1001264","EFO_1002048","EFO_1000690","MONDO_0002158","Orphanet_68364","EFO_1001996","EFO_0004289","EFO_0004272","EFO_0000183","EFO_0000616","EFO_0000685","EFO_0000403","EFO_0003929","EFO_0000222","MONDO_0000870","MONDO_0019469","EFO_0004599","EFO_0000621","EFO_0000311","EFO_0000211","MONDO_0005301","EFO_0000095","MONDO_0005147","EFO_0001421","EFO_0006927","EFO_1001947","MONDO_0002367","EFO_1000560","Orphanet_2781","HP_0100727"],"count":71},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 61 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201637","drugType":"Enzyme","blackBoxWarning":false,"name":"LIPASE (PANCRELIPASE)","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lipase","Lipase (pancrelipase)"],"crossReferences":{"DailyMed":["lipase%20(pancrelipase)"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1996 and has 1 investigational indication."}
{"id":"CHEMBL1201719","drugType":"Unknown","blackBoxWarning":false,"name":"PETROLATUM, WHITE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maroline"],"synonyms":["Petrolatum, white","White petrolatum"],"crossReferences":{"DailyMed":["petrolatum,%20white"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 investigational indications."}
{"id":"CHEMBL1232147","canonicalSmiles":"Nc1nc(N)c2c(OCC3CCN(Cc4cccc(Cl)c4Cl)CC3)cccc2n1","inchiKey":"XVLUVRFYGVJKGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232147","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234032","canonicalSmiles":"c1ccc2c(-c3ccncc3)n[nH]c2c1","inchiKey":"MSRXUUDVRNWSTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234032","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08113"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234956","canonicalSmiles":"O=C(O)C[C@H](OC(=O)/C=C/c1ccc(O)cc1)[C@@H](OC(=O)/C=C/c1ccc(O)cc1)C(=O)O","inchiKey":"VJLMRHSHSNLOGC-NOPZTHQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FR258900","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FR258900"],"crossReferences":{"drugbank":["DB08322"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255871","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1=O","inchiKey":"MQZIGYBFDRPAKN-UWFIBFSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASTAXANTHIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["All-trans-astaxanthin","Astareal","Astaxanthin","Bioastin","E161j","NSC-635689","Ovoester"],"crossReferences":{"drugbank":["DB06543"],"chEBI":["40968"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1277001","canonicalSmiles":"CC(C)S(=O)(=O)NC[C@H](C)c1ccc(-c2ccc(CCNS(C)(=O)=O)cc2)cc1","inchiKey":"ULRDYYKSPCRXAJ-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIBAMPATOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY 451395","LY-451395","LY451395","Mibampator"],"crossReferences":{"drugbank":["DB12717"]},"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL13852","canonicalSmiles":"c1ccc(C2CC2)c(OCC2=NCCN2)c1","inchiKey":"YAORIDZYZDUZCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIRAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cirazoline"],"crossReferences":{"PubChem":["104171120","11110893","11113761","124879511","124879513","144203646","170466314","26751944","26751945","50104620","50104621","90341611"],"Wikipedia":["Cirazoline"],"drugbank":["DB09202"]},"childChemblIds":["CHEMBL1255646"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1408862","canonicalSmiles":"O=[N+]([O-])C(Br)(CO)CO","inchiKey":"LVDKZNITIUWNER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRONOPOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-bromo-2-nitropropane-1,3-diol","Bronopol","NSC-141021"],"crossReferences":{"PubChem":["144205632","144210446","225144251","26757474"],"drugbank":["DB13960"],"chEBI":["31306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14145","canonicalSmiles":"c1ccc(-c2c[nH]cn2)cc1","inchiKey":"XHLKOHSAWQPOFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Phenylimidazole","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Phenylimidazole"],"crossReferences":{"drugbank":["DB03254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL141889","canonicalSmiles":"Cc1cnc(NCC(F)(F)c2ccccn2)c(=O)n1CC(=O)NCc1ncccc1F","inchiKey":"JXHWVKOKYDAROD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL141889","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07548"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1430","canonicalSmiles":"CC(C)(S)[C@@H](N)C(=O)O","inchiKey":"VVNCNSJFMMFHPL-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENICILLAMINE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cuprimine","D Mercaptovaline","D Penicillamine","Depen","Distamine","Trolovol"],"synonyms":["D-3-mercaptovaline","Dimethylcysteine","NSC-758421","NSC-81549","Penicillamine"],"crossReferences":{"DailyMed":["penicillamine"],"PubChem":["144204450","29215023"],"TG-GATEs":["99"],"Wikipedia":["Penicillamine"],"drugbank":["DB00859"],"chEBI":["7959"]},"childChemblIds":["CHEMBL1469737"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 7 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1491","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl","inchiKey":"HTIQEAQVCYTUBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMLODIPINE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Astudal 5","Istin","Norvas","Norvasc"],"synonyms":["Amlodipine","CKD-330 COMPONENT AMLODIPINE","HGP-0904","HGP0904"],"crossReferences":{"DailyMed":["amlodipine%20benzoate","amlodipine%20besylate"],"PubChem":["124893198","225144262","29217715","50111725"],"Wikipedia":["Amlodipine"],"drugbank":["DB00381"],"chEBI":["2668"]},"childChemblIds":["CHEMBL1200402","CHEMBL4594262","CHEMBL1200984"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003086","EFO_0003777","EFO_0000278","EFO_0003095","EFO_0000275","EFO_0004234","EFO_0000401","MONDO_0007254","EFO_1000013","EFO_0000373","EFO_0000538","EFO_1001145","EFO_0007148","EFO_0003913","EFO_0003914","MONDO_0002050","EFO_1001375","EFO_0003144","EFO_1001996","EFO_0000712","EFO_0003884","EFO_0004285","EFO_0000400","MONDO_0000477","HP_0002140","HP_0003124","HP_0000093","EFO_0001645","EFO_0000319","EFO_0004911","EFO_0000537","EFO_0000195","HP_0012664","MONDO_0001134","Orphanet_79292","MONDO_0021187","EFO_0000764","EFO_0001421","EFO_0000612","MONDO_0005148","Orphanet_231214","EFO_0000668","MONDO_0001422"],"count":44},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 13 approved and 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1566","canonicalSmiles":"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"XUFXOAAUWZOOIT-SXARVLRPSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ACARBOSE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acarbose","Glucobay","Precose"],"synonyms":["Acarbose","BAY G 5421","BAY-G-5421","NSC-758915"],"crossReferences":{"DailyMed":["acarbose"],"PubChem":["144205150","170464784"],"TG-GATEs":["116"],"Wikipedia":["Acarbose"]},"linkedTargets":{"rows":["ENSG00000257335","ENSG00000243480","ENSG00000187733"],"count":3},"linkedDiseases":{"rows":["HP_0003124","EFO_0003095","EFO_0001645","EFO_0005252","EFO_0001073","EFO_0000537","EFO_0003914","GO_0007568","EFO_0000589","EFO_0004220","EFO_0004593","EFO_0000195","MONDO_0005148","EFO_0000400","EFO_0007318"],"count":15},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 12 investigational indications."}
{"id":"CHEMBL1609","canonicalSmiles":"O=C(O)C(O)c1ccccc1","inchiKey":"IWYDHOAUDWTVEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANDELIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dl-mandelic acid","Mandelic Acid","Mandelic acid","NSC-7925","Paramandelic acid","Racemic mandelic acid"],"crossReferences":{"PubChem":["26513818","29217780","29217781","29218027","56422214"],"Wikipedia":["Mandelic_acid"],"drugbank":["DB13218"],"chEBI":["35825"]},"childChemblIds":["CHEMBL1600303","CHEMBL3248126"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL1624767","canonicalSmiles":"O=S(=O)(O)CC(S)CS","inchiKey":"JLVSRWOIZZXQAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-DIMERCAPTO-1-PROPANESULFONIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-dimercapto-1-propanesulfonic acid"],"crossReferences":{"chEBI":["888"]},"childChemblIds":["CHEMBL1569746"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1652621","canonicalSmiles":"Cc1c(CN(C)C(=O)/C=C/c2cnc3c(c2)CCC(=O)N3)oc2ccccc12","inchiKey":"QXTWSUQCXCWEHF-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFN-1252","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFN-1252","API 1252","API-1252","Afn-1252","DEBIO-1452","DEBIO1452"],"crossReferences":{"drugbank":["DB12658"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL166444","canonicalSmiles":"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C","inchiKey":"CCCIJQPRIXGQOE-XWSJACJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRIBOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyltrienolone","Metribolone","NSC-92858","R 1881","R-1881"],"crossReferences":{"Wikipedia":["Metribolone"],"drugbank":["DB02998"],"chEBI":["379896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1730","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1","inchiKey":"GPRBEKHLDVQUJE-QSWIMTSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTAXIME","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefotaxim hikma","Cefotaxime"],"crossReferences":{"DailyMed":["cefotaxime%20sodium"],"PubChem":["26753348","50105699","90340932"],"drugbank":["DB00493"],"chEBI":["204928"]},"childChemblIds":["CHEMBL1010"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL1740659","canonicalSmiles":"C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N","inchiKey":"JTLXCMOFVBXEKD-FOWTUZBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURSULTIAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Judolor"],"synonyms":["Aliaron f","Alinamin-f","Fursultiamin","Fursultiamine","Fursultiamine hydrochloride","TTFD"],"crossReferences":{"PubChem":["144206542"],"drugbank":["DB08966"]},"childChemblIds":["CHEMBL1705673"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1742408","canonicalSmiles":"c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2","inchiKey":"MEEQBDCQPIZMLY-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSEMOZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MN-305","Mkc-242","Osemozotan"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1743062","drugType":"Antibody","blackBoxWarning":false,"name":"RAMUCIRUMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyramza"],"synonyms":["1121B","IMC-1121B","LY3009806","Ramucirumab"],"crossReferences":{"DailyMed":["ramucirumab"],"DrugCentral":["4917"]},"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_1000657","EFO_1001469","MONDO_0021063","EFO_0005952","EFO_0000708","EFO_0000228","EFO_1001951","MONDO_0001056","EFO_0000178","EFO_1000044","EFO_0000588","EFO_0000389","EFO_0000182","MONDO_0005411","EFO_1000532","EFO_0000326","EFO_0008528","EFO_0000616","EFO_0002618","EFO_0003897","EFO_0005922","EFO_0002916","EFO_0000503","MONDO_0007576","EFO_0004243","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001961","EFO_1000576","EFO_1000581","EFO_0006544","MONDO_0003219","EFO_1000895","MONDO_0024880","EFO_0000181","EFO_0000519","EFO_0001376"],"count":42},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 34 investigational indications."}
{"id":"CHEMBL181","canonicalSmiles":"CC1=NS(=O)(=O)c2cc(Cl)ccc2N1","inchiKey":"GDLBFKVLRPITMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAZOXIDE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diazoxide","Eudemine","Eudimine","Hyperstat","Mutabase","Proglycem"],"synonyms":["Diazoxide","Diazoxidum","Eudemine injection","Hypertonalum","NSC-64198","NSC-76130","SCH 6783","SCH-6783","SRG 95213","SRG-95213"],"crossReferences":{"DailyMed":["diazoxide"],"PubChem":["11111111","11113823","124879964","144203683","170465328","26747146","26751995","50104671","56422090","855807"],"Wikipedia":["Diazoxide"],"drugbank":["DB01119"],"chEBI":["4495"]},"childChemblIds":["CHEMBL4297276"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000121361"],"count":2},"linkedDiseases":{"rows":["EFO_0004211","EFO_0000589","Orphanet_739","MONDO_0002050","MONDO_0024503","MONDO_0005147","HP_0001943","MONDO_0002177","MONDO_0024677","MONDO_0005148","EFO_0001073","EFO_0000537"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 5 investigational indications."}
{"id":"CHEMBL184023","canonicalSmiles":"CCCC/C(C)=C/C=C(\\C)C(=O)c1c(O)cc(CCC/C=C/NC(=O)OC)oc1=O","inchiKey":"QBIHIGNYQFSBGW-NOTXRLOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESMETHYL MYXOPYRONIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08226"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1928262","canonicalSmiles":"CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc2c(CC)n(CCOC)nc2c(=O)[nH]1","inchiKey":"YPFZMBHKIVDSNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GISADENAFIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gisadenafil","UK-369,003","UK-369003"],"crossReferences":{"drugbank":["DB11902"]},"childChemblIds":["CHEMBL2103843"],"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["HP_0000802","EFO_1000781","EFO_0000341","EFO_0000284"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1980297","canonicalSmiles":"Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12","inchiKey":"WPHKIQPVPYJNAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILORASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Abt-348, a-968660"],"synonyms":["A-968660","A-968660.0","ABBOTT-968660","ABT-348","Abt-348","Ilorasertib"],"crossReferences":{"PubChem":["103904272"],"drugbank":["DB11694"]},"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000037280","ENSG00000105146","ENSG00000113721","ENSG00000010810","ENSG00000134853","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000178999","ENSG00000102755","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000197122"],"count":18},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0024880","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2095212","canonicalSmiles":"Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1","inchiKey":"PBAPPPCECJKMCM-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRABEGRON","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betmiga","Myrbetriq","Myrbetriq granules"],"synonyms":["Betanis","Mirabegron","YM-178","YM178"],"crossReferences":{"DailyMed":["mirabegron"],"drugbank":["DB08893"],"chEBI":["65349"]},"childChemblIds":["CHEMBL3542362"],"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0006865","HP_0002571","EFO_0008507","EFO_0001073","EFO_0003843","EFO_0000660","HP_0011277","EFO_0003896","HP_0012664","MONDO_0005301","EFO_1001121","EFO_0003144","EFO_0004253","EFO_0001421","HP_0000020","MONDO_0005180","EFO_0005109","EFO_1000781","EFO_1000869","HP_0000011","HP_0000103"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 4 approved and 11 investigational indications."}
{"id":"CHEMBL2103830","canonicalSmiles":"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC","inchiKey":"GKDRMWXFWHEQQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSTAMATINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fostamatinib","R-788","R-788 FREE ACID","R-935788","R-935788 FREE ACID","R788 FREE ACID","R935788 FREE ACID"],"crossReferences":{"DailyMed":["fostamatinib%20disodium"],"PubChem":["174006453"],"drugbank":["DB12010"]},"childChemblIds":["CHEMBL3989516"],"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0044903","EFO_1000710","EFO_0001642","MONDO_0008170","EFO_0000403","EFO_1001264","EFO_0004194","HP_0001873","EFO_0003106","MP_0001914","EFO_0007160","MONDO_0100096","EFO_0002690","EFO_0000574"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 15 investigational indications."}
{"id":"CHEMBL2103870","canonicalSmiles":"Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1","inchiKey":"UFSKUSARDNFIRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMACAFTOR","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lumacaftor","VRT 826809","VRT-826809","VX 809","VX-809"],"crossReferences":{"DailyMed":["lumacaftor"],"drugbank":["DB09280"]},"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["EFO_0001421","Orphanet_586","HP_0001657"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for cystic fibrosis and has 1 investigational indication."}
{"id":"CHEMBL2104251","canonicalSmiles":"C=C(C#N)C(=O)OCCCC","inchiKey":"JJJFUHOGVZWXNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENBUCRILATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Histoacryl","Indermil"],"synonyms":["Enbucrilate","Glustitch","Medibond","Medicryl","N-butyl cyanoacrylate","N-butyl-2-cyanoacrylate","Periacryl","Vetbond"],"crossReferences":{"drugbank":["DB12358"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2104991","canonicalSmiles":"Cl.c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2","inchiKey":"PYPPENBDXAWXJC-QNTKWALQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VABICASERIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110670","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCA-136","Vabicaserin hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105275","canonicalSmiles":"CNC(C)CC1CCCCC1","inchiKey":"JCRIVQIOJSSCQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPYLHEXEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dristan inhaler"],"synonyms":["Benzedrex","Dl-propylhexedrine","Hydromethamphetamine","NSC-32410","Propylhexedrine","Propylhexedrine dl-form"],"crossReferences":{"PubChem":["144206628"],"drugbank":["DB06714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105656","canonicalSmiles":"CCO.O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c([O-])nc3ncccc32)CC1.[K+]","inchiKey":"DYXNKCSVHJFUSS-LEVQAPRMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TELCAGEPANT POTASSIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL236593","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Telcagepant potassium","Telcagepant potassium ethanol","Telcagepant potassium salt monoethanolate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105794","canonicalSmiles":"[Na+].[OH-]","inchiKey":"HEMHJVSKTPXQMS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM HYDROXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aetznatron","Caustic soda","E-524","INS-524","NSC-135799","Natrii hydroxydum","Promoter 3308b","Sodium hydroxide","Sodium hydroxide solutions","Stamperprep","Tosoh pearl"],"crossReferences":{"DrugCentral":["4636"],"drugbank":["DB11151"],"chEBI":["32145"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105977","canonicalSmiles":"C[N+]1(CC2CC2)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.[Br-]","inchiKey":"WDURTRGFUGAJHA-GSWUYBTGSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETROPIUM BROMIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110773","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alginor","Cimetropium bromide","DA-3177"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106357","canonicalSmiles":"O=C(O)CCC(=O)c1ccc2c(c1)-c1cccc3cccc-2c13","inchiKey":"QOBAOSCOLAGPKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORANTYRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Florantyrone"],"crossReferences":{"drugbank":["DB08975"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107457","canonicalSmiles":"COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC","inchiKey":"QQQIECGTIMUVDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITOPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Itopride","NSC-759643"],"crossReferences":{"drugbank":["DB04924"]},"childChemblIds":["CHEMBL2139257"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000087085"],"count":2},"linkedDiseases":{"rows":["EFO_0008588","EFO_0010282","EFO_0000555","EFO_1000948","HP_0002019","EFO_0008533"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108126","drugType":"Unknown","blackBoxWarning":false,"name":"PSYLLIUM HUSK","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hydrocil instant","Modane bulk","Mylanta fiber","Syllact"],"synonyms":["Plantago seed psyllium hydrophylic mucilloid","Psyllium 85%","Psyllium husk","Psyllium husk, unspecified","Psyllium hydrophilic mucilloid","Psyllium mucilloid","Psyllium seed coat"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108248","drugType":"Antibody","blackBoxWarning":false,"name":"ANATUMOMAB MAFENATOX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Anyara"],"synonyms":["ABR-214936","Anatumomab mafenatox"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108390","drugType":"Unknown","blackBoxWarning":false,"name":"FIBRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Factor 1a","Fibrin","Human fibrin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL2108462","drugType":"Unknown","blackBoxWarning":false,"name":"GALASOMITE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Synsorb pk"],"synonyms":["Galasomite","SBI-0067"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108546","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGASPARGASE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oncaspar"],"synonyms":["Asparaginase compd with polyethylene glycol","Asparaginase e. coli compd with polyethylene glycol","Peg-asparaginase","Pegaspargase"],"crossReferences":{"DailyMed":["pegaspargase"],"DrugCentral":["5082"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL2108566","drugType":"Antibody","blackBoxWarning":false,"name":"NERELIMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Humicade"],"synonyms":["BAY X 1351","BAY-103356","BAY-X 1351","BAY-X-1351","BAYX-1351","CDP-571","Nerelimomab","TNF MAB","TNF-MAB"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108666","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(sup 90)y-dota-hll2","2F35K89X9W","90Y-DOTA-HLL2","90y-epratuzumab","S9S0Y-DOTA-HLL2","Y-90-dota-hll2","Yttrium y 90 epratuzumab tetraxetan"],"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000403","MONDO_0018906","EFO_0000094"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108906","drugType":"Small molecule","blackBoxWarning":false,"name":"BELLADONNA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atropa bella-donna whole","Atropa belladonna","Belladonna","Belladonna extract","Belladonna total alkaloids","Belladonna whole","Deadly nightshade","Deadly nightshade whole"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2111047","canonicalSmiles":"CCCC(Cc1ccccc1)N1CCCC1","inchiKey":"OJCPSBCUMRIPFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROLINTANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prolintan","Prolintane"],"crossReferences":{"drugbank":["DB13438"]},"childChemblIds":["CHEMBL2107189"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2145077","canonicalSmiles":"COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2.Cl","inchiKey":"HLUKNZUABFFNQS-ZMBIFBSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IVABRADINE HYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL471737","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corlanor","Procoralan"],"synonyms":["AMG 998","AMG-998","Corlentor","Ivabradine","Ivabradine hcl","Ivabradine hydrochloride","S 16257","S-16257-2"],"crossReferences":{"DailyMed":["ivabradine%20hydrochloride"],"PubChem":["144206355"],"chEBI":["85969"]},"linkedTargets":{"rows":["ENSG00000138622"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000373"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for congestive heart failure and heart failure."}
{"id":"CHEMBL2146086","canonicalSmiles":"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1.O=S(=O)(O)c1ccccc1","inchiKey":"ARQUTWAXTHJROR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRENOLANIB BESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105728","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["596-26","ARO-002-26","CP-868","CP-868,596-26","CP-868596-26","Crenolanib besilate","Crenolanib besylate"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2218894","canonicalSmiles":"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+]","inchiKey":"ZGGHKIMDNBDHJB-CALJPSDSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUVASTATIN SODIUM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2220442","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dorisin xl","Fluvastatin sodium","Lescol","Lescol xl","Luvinsta xl","Nandovar xl","Pinmactil","Stefluvin xl"],"synonyms":["Almastatin","Canef","Cranoc","Fluindostatin","Fluvastatin sodium","Fluvastatin sodium salt","Fractal","Lipaxan","Lochol","Locol","Primexin","Vastin","XU 62-320","XU-62-320"],"crossReferences":{"DailyMed":["fluvastatin%20sodium"]},"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0000589","HP_0003124","MONDO_0007254","EFO_0004911"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for familial hypercholesterolemia and hypercholesterolemia and has 1 investigational indication."}
{"id":"CHEMBL2272031","canonicalSmiles":"CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\\C)[C@@H](O)[C@H](O)[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O","inchiKey":"AGJUUQSLGVCRQA-SWOUQTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cantricin","Cogomycin","Femifect","Fungchromin","Lagosin","NSC-105388","NSC-276732","Pentamycin","Pruri-ex"],"crossReferences":{"drugbank":["DB13571"],"chEBI":["31639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233209","canonicalSmiles":"CC(C)(N)c1ccc(-c2nc(Nc3ccc(CCN4CCOCC4)cc3)ncc2Cl)cc1","inchiKey":"CJSSYVIHFXDFFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233209","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02491"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2387408","canonicalSmiles":"CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(=O)O)CC(=O)O)c(OC)cc2[C@@H](c2ccccc2)N1","inchiKey":"CZGVOBIGEBDYTP-VSGBNLITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINERIXIBAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK2330672","Gsk-2330672","Gsk2330672","Linerixibat"],"crossReferences":{"drugbank":["DB11729"]},"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0001751","MONDO_0019072","MONDO_0005148"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL253629","canonicalSmiles":"NC(=O)c1[nH]c2ccc(Br)cc2c1S(=O)(=O)N1CCCC1","inchiKey":"FEPUPYVRZUWCQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253629","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08211"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257341","canonicalSmiles":"CC(C)Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1","inchiKey":"FQYJTHIYAQQJAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257341","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08352"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278172","canonicalSmiles":"CCOC(=O)c1ccc(N)cc1","inchiKey":"BLFLLBZGZJTVJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOCAINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aezodent","Americaine","Anthisan plus","Baby anbesol","Burneze","Children's chloraseptic","Dequacaine","Lanacane","Medilave","Nestosyl","Orajel","Tyrosolven","Tyrozets"],"synonyms":["AR-01","AR01","Anaesthesin","Benzocaine","Benzocainum","Ethyl aminobenzoate","Ethyl p-aminobenzoate","Ethyl paba","Flavamed","NSC-41531","NSC-4688","Norcaine","Parathesin","Parathesine","Subcutin"],"crossReferences":{"PubChem":["11112244","144203942","144211466","170465463","26747880","56422766"],"Wikipedia":["Benzocaine"],"drugbank":["DB01086"],"chEBI":["116735"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 approved and 5 investigational indications."}
{"id":"CHEMBL284092","canonicalSmiles":"CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1","inchiKey":"QOIGKGMMAGJZNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEPIRONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ariza","BMY-13805","Gepirone","ORG-13011","Variza"],"crossReferences":{"Wikipedia":["Gepirone"],"drugbank":["DB12184"]},"childChemblIds":["CHEMBL1204187"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL29404","canonicalSmiles":"Cc1nc(OCCCCCN2CCCCC2)cc(-c2ccc(F)cc2)n1","inchiKey":"SZSHJTJCJOWMHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENECADIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enecadin"],"crossReferences":{"drugbank":["DB13032"]},"childChemblIds":["CHEMBL2401778"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL295830","canonicalSmiles":"NC1(C(=O)O)CCCC1","inchiKey":"NILQLFBWTXNUOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOLEUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Amino-Cyclopentanecarboxylic Acid","1-Aminocyclopentanecarboxylic Acid","Cycloleucine","Cycloleucine1-Amino-Cyclopentanecarboxylic Acid"],"crossReferences":{"PubChem":["67889"],"Wikipedia":["Cycloleucine"],"drugbank":["DB04620"],"chEBI":["40547"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL310554","canonicalSmiles":"O=C[C@H](CC(=O)O)NC(=O)c1cncc(-c2ccc(C(=O)O)cc2)c1","inchiKey":"JNRAPROKLOUIRA-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL310554","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08251"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3181870","canonicalSmiles":"Cc1ncc(COP(=O)(O)O)c(C=O)c1O.O","inchiKey":"CEEQUQSGVRRXQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAL PHOSPHATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL82202","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-82388","Pyridoxal 5-phosphate","Pyridoxal 5-phosphate monohydrate","Pyridoxal phosphate","Pyridoxal phosphate hydrate","Pyridoxal phosphate monohydrate"],"crossReferences":{"PubChem":["144205952","170466028"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3188084","canonicalSmiles":"N#CCCC(Br)(C#N)CBr","inchiKey":"DHVLDKHFGIVEIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3188084","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212268"],"drugbank":["DB14199"],"chEBI":["62823"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL320049","canonicalSmiles":"O=C(Cc1cccs1)NCB(O)O","inchiKey":"VXAPSUDMBNWYNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL320049","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02094"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545174","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2881078","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2881078"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["HP_0004326"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545358","drugType":"Small molecule","blackBoxWarning":false,"name":"4SC-203","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4sc 203","4sc-203"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL363614","canonicalSmiles":"c1ccc2occc2c1","inchiKey":"IANQTJSKSUMEQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOFURAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzofuran"],"crossReferences":{"PubChem":["144214015","17390023","26752901","26752902","85272551"],"Wikipedia":["Benzofuran"],"drugbank":["DB04179"],"chEBI":["35260"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833317","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC PYROPHOSPHATE CITRATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Triferic","Triferic avnu"],"synonyms":["Ferric pyrophosphate citrate","H-61","H61","SFP"],"crossReferences":{"DailyMed":["ferric%20pyrophosphate%20citrate"],"DrugCentral":["5122"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for chronic kidney disease and has 2 investigational indications."}
{"id":"CHEMBL3833340","canonicalSmiles":"C[C@H]1[C@H](NC(=O)/C(=N\\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O.NCCCC[C@H](N)C(=O)O","inchiKey":"KPPBAEVZLDHCOK-JHBYREIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZTREONAM LYSINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL158","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cayston"],"synonyms":["Aztreonam l-lysine salt","Aztreonam lysinate","Aztreonam lysine","CORUS-1020","CORUS1020","Corus 1020"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL38700","canonicalSmiles":"Nc1nc(=O)n([C@@H]2C=C[C@H](CO)O2)cc1F","inchiKey":"HSBKFSPNDWWPSL-VDTYLAMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELVUCITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-l-fd4c","ACH-126,443","ACH-126443","Beta-l-fd4c","Elvucitabine","L-fd4c"],"crossReferences":{"Wikipedia":["Elvucitabine"],"drugbank":["DB06236"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989750","canonicalSmiles":"N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.O=S(=O)(O)O","inchiKey":"CVCQAQVBOPNTFI-AAONGDSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCOSAMINE SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL493287","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolenio","Glusartel"],"synonyms":["Faximin","Glucosamine sulf ","Glucosamine sulfate","Glucosamine sulfate salt","Tiocondramina"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989858","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].O.O.O.O.[Mg+2]","inchiKey":"XKPKPGCRSHFTKM-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM ACETATE TETRAHYDRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200691","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Magnesium acetate tetrahydrate"],"crossReferences":{"drugbank":["DB09409"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989943","canonicalSmiles":"CS(=O)(=O)CCC#N","inchiKey":"LQFRYKBDZNPJSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPANSUTRILE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dapansutrile","OLT-1177","OLT1177"],"linkedTargets":{"rows":["ENSG00000162711"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0000756","EFO_1001207","EFO_1001165"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL408","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2","inchiKey":"GXPHKUHSUJUWKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROGLITAZONE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Hepatotoxicity"],"year":1997},"tradeNames":["Prelay","Rezulin","Romozin"],"synonyms":["CI-991","CS-045","GR-92132X","GR92132X","Rezulin","Troglitazone"],"crossReferences":{"PubChem":["137275811","144205672","144210788","170465091","174007238","26755242","26755243","26757864","29216382"],"Wikipedia":["Troglitazone"],"drugbank":["DB00197"],"chEBI":["9753"]},"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0000400","EFO_0000691"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for diabetes mellitus and has 1 investigational indication. It was withdrawn in United States  in 1997 due to Hepatotoxicity."}
{"id":"CHEMBL4297243","drugType":"Cell","blackBoxWarning":false,"name":"EMIPLACEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emiplacel","PLX-PAD","PLXPAD"],"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297352","canonicalSmiles":"C[C@]1(CS(=O)(=O)N2CCC(Oc3ccc(Cl)cn3)CC2)NC(=O)NC1=O","inchiKey":"SFJFBTPHDHUUPU-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1236","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD1236","Azd 1236","Azd-1236","Azd1236"],"crossReferences":{"drugbank":["DB11961"]},"linkedTargets":{"rows":["ENSG00000100985","ENSG00000262406"],"count":2},"linkedDiseases":{"rows":["Orphanet_586","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297437","canonicalSmiles":"O=C1N=C2C=CC=CN2C12Cc1ccccc1C2","inchiKey":"QZWYXEBIQWJXAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ST-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST101","St-101","St101","ZSET-1446"],"crossReferences":{"drugbank":["DB12621"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297912","drugType":"Unknown","blackBoxWarning":false,"name":"BIFIDOBACTERIUM SPP.","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifidobacteria","Bifidobacterium","Bifidobacterium nos","Bifidobacterium spp."],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297928","drugType":"Unknown","blackBoxWarning":false,"name":"NOMACOPAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coversin","Nomacopan","REV-576","REV-675","REV675","rEV576"],"linkedTargets":{"rows":["ENSG00000213906","ENSG00000213903","ENSG00000106804"],"count":3},"linkedDiseases":{"rows":["Orphanet_447","EFO_0007187"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297963","drugType":"Unknown","blackBoxWarning":false,"name":"GP-100 ANTIGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gp-100 antigen","Gp100 antigen","Melanocyte protein pmel","Melanoma-associated me20 antigen","Premelanosome protein"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL429910","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1","inchiKey":"JVHXJTBJCFBINQ-ADAARDCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPAGLIFLOZIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Forxiga"],"synonyms":["BMS-512148","BMS-512148-05","Dapagliflozin","LYN-045"],"crossReferences":{"DailyMed":["dapagliflozin"],"Wikipedia":["Dapagliflozin"],"drugbank":["DB06292"],"chEBI":["85078"]},"childChemblIds":["CHEMBL3125457","CHEMBL3125455","CHEMBL3125318","CHEMBL3125316","CHEMBL3125317","CHEMBL2103802","CHEMBL3125456","CHEMBL3125458"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000275","EFO_0003095","EFO_0000401","MONDO_0007254","EFO_1001249","EFO_0000373","EFO_0000266","HP_0001824","EFO_1000783","EFO_0003144","EFO_0003884","EFO_0004285","EFO_0000400","EFO_0003940","EFO_0002618","Orphanet_214","EFO_0009104","EFO_0002687","HP_0001919","EFO_0001645","HP_0000093","EFO_0004236","EFO_0004194","EFO_0001073","EFO_0000660","EFO_0001663","EFO_0000537","EFO_0000195","GO_0007568","HP_0012664","MONDO_0100096","EFO_1001121","MONDO_0005147","HP_0003074","MONDO_0004975","EFO_1001207","EFO_0000612","MONDO_0005148","EFO_1000899"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 22 investigational indications."}
{"id":"CHEMBL440294","canonicalSmiles":"NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1","inchiKey":"AXKPFOAXAHJUAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPAMPERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Floropipamide","NSC-759178","Pipamperone","Pipamperone hydrochloride","Pipaneperone","R 3345","R-3345"],"crossReferences":{"PubChem":["29217622","50111712"],"Wikipedia":["Pipamperone"],"drugbank":["DB09286"],"chEBI":["78549"]},"childChemblIds":["CHEMBL2361301"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL441687","canonicalSmiles":"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C","inchiKey":"LPLVUJXQOOQHMX-QWBHMCJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCYRRHIZIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-glycyrrhizin","18.beta.-glycyrrhizic acid","E958","Glycyron","Glycyrrhetinic acid","Glycyrrhizic Acid","Glycyrrhizic acid","Glycyrrhizin","Glycyrrhizinic acid","NSC-167409","NSC-234419","Potenlini"],"crossReferences":{"PubChem":["144205073","144206976","144213802","26755251"],"drugbank":["DB13751"],"chEBI":["15939"]},"childChemblIds":["CHEMBL3561931","CHEMBL4536688","CHEMBL1923952"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL456163","canonicalSmiles":"CC(=O)Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1","inchiKey":"CWQKPKYIMQTGJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456163","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594216","canonicalSmiles":"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)CCC2=O)C(C)C)cc1)C(C)C","inchiKey":"IEDXPSOJFSVCKU-HOKPPMCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MMAE","MONOMETHYL AURISTATIN E","Monomethylauristatin e","PAB-MMAE","SGD-1010","Vedotin","Vedotin (fragment)","Vedotin fragment","Vedotin radical","conjugated form of mc-vc-PAB-MMAE"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594339","drugType":"Antibody","blackBoxWarning":false,"name":"OMODENBAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["514G3","514g3","Omodenbamab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594519","drugType":"Unknown","blackBoxWarning":false,"name":"ADG-106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADG-106","ADG106","Adg-106","Adg106"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650329","canonicalSmiles":"Cc1c(-c2[nH]c3ccc(C4CCN(CC(N)=O)CC4)cc3c2C(C)C)cn2ncnc2c1C","inchiKey":"SNFVHLQYHFQOEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFIMETORAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afimetoran","BMS-986256","Bms-986256"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650382","drugType":"Unknown","blackBoxWarning":false,"name":"BRII-196","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amubarvimab","BRII-196","Brii-196"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650415","drugType":"Unknown","blackBoxWarning":false,"name":"PF-05230907","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fxa variant i16l","PF-05230907","Pf-05230907"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650425","drugType":"Unknown","blackBoxWarning":false,"name":"TG-1801","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TG-1801","Tg-1801"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650460","drugType":"Antibody","blackBoxWarning":false,"name":"PLUTAVIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Covi-amg"],"synonyms":["Affinity matured covi-guard","Covi-amg","Covi-drops","Plutavimab","STI-2020","STI-2099","STI2020","STI2099","Sti-2020"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650486","drugType":"Antibody","blackBoxWarning":false,"name":"ZANSECIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3127804","LY3127804","Ly3127804","Zansecimab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650894","canonicalSmiles":"CCCc1c(-c2ccccc2)nn(-c2ccccn2)c1O","inchiKey":"LQKQLKMTJOMCMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISUZINAXIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650358"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL467773","canonicalSmiles":"CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"HOVAGTYPODGVJG-PZRMXXKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL467773","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02100"],"chEBI":["55507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802167","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-770767","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-770767","Bms-770767"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4802191","drugType":"Unknown","blackBoxWarning":false,"name":"BEMNIFOSBUVIR HEMISULFATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-527","At-527","Bemnifosbuvir hemisulfate"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL488093","canonicalSmiles":"Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O","inchiKey":"SIXLXDIJGIWWFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITINOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-759229","Pyrithioxin","Pyrithioxine","Pyrithioxine hydrochloride","Pyritinol"],"crossReferences":{"PubChem":["29217898"],"Wikipedia":["Pyritinol"],"drugbank":["DB13084"]},"childChemblIds":["CHEMBL2355482"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL49429","canonicalSmiles":"Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1","inchiKey":"PPHTXRNHTVLQED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIXIVAPTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lixar"],"synonyms":["CRTX 080","CRTX-080","Lixivaptan","VPA 985","VPA-985","Vpa-985","WAY-VPA-985"],"crossReferences":{"Wikipedia":["Lixivaptan"],"drugbank":["DB06666"]},"childChemblIds":["CHEMBL3526685"],"linkedTargets":{"rows":["ENSG00000126895"],"count":1},"linkedDiseases":{"rows":["EFO_0008620","HP_0002902","EFO_0000373","EFO_1001496"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL501122","canonicalSmiles":"CCO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1","inchiKey":"ZCCUWMICIWSJIX-NQJJCJBVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTAROLINE FOSAMIL","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ceftaroline fosamil","Ceftaroline fosamil anhydrous","PPI-0903","TAK 599","TAK-599"],"crossReferences":{"DailyMed":["ceftaroline%20fosamil"],"Wikipedia":["Ceftaroline_fosamil"],"drugbank":["DB06590"],"chEBI":["70718"]},"childChemblIds":["CHEMBL4790265","CHEMBL3544973"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 8 investigational indications."}
{"id":"CHEMBL541758","canonicalSmiles":"Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCOCC4)c3Cl)c2n1.[Cl-]","inchiKey":"ZNHJDJYKDVGQSH-JMAPEOGHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FASITIBANT CHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL218427","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasitibant chloride","Men16132"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL560739","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC","inchiKey":"DCSUBABJRXZOMT-IRLDBZIGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL560739","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00604"],"chEBI":["3720"]},"childChemblIds":["CHEMBL1546244"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62381","canonicalSmiles":"CCCC(=O)[O-].[Na+]","inchiKey":"MFBOGIVSZKQAPD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BUTYRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyric acid sodium salt","Butyric acid, sodium salt","NSC-174280","Sodium butyrate"],"crossReferences":{"PubChem":["144206103","563607"],"Wikipedia":["Sodium_butyrate"],"chEBI":["64103"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL64130","canonicalSmiles":"CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O","inchiKey":"DPHUWDIXHNQOSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPABUCASIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Acetylfuranonaphthoquinone","2-acetylfuro-1,4-naphthoquinone","BBI-608","BBI608","Napabucasin"],"crossReferences":{"drugbank":["DB12155"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL71927","canonicalSmiles":"CCN1c2cc([N+](=O)[O-])ccc2N(C)C(=O)c2cccnc21","inchiKey":"YCFJZPGDTZVVSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL71927","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08665"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL779","canonicalSmiles":"CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O","inchiKey":"WOXKDUGGOYFFRN-IIBYNOLFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TADALAFIL","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adcirca","Cialis"],"synonyms":["IC-351","IC351","LY-450190","LY450190","NSC-750236","NSC-759172","Tadalafil","Tadalafil mylan","Trans-tadalafil"],"crossReferences":{"DailyMed":["tadalafil"],"PubChem":["144206195","170464819","26719828","49666420"],"Wikipedia":["Tadalafil"],"drugbank":["DB00820"],"chEBI":["71940"]},"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","Orphanet_98895","EFO_0004718","MONDO_0002009","EFO_0004234","HP_0000802","EFO_0000284","Orphanet_98473","EFO_1000948","EFO_0000373","EFO_0000266","EFO_1001145","EFO_1000044","EFO_0004714","EFO_0003099","EFO_0004253","EFO_0000712","EFO_0004244","EFO_0002499","EFO_0000717","EFO_0002618","EFO_0000616","MONDO_0005149","EFO_0000694","HP_0001952","MONDO_0000153","EFO_0009200","HP_0200023","EFO_0001073","EFO_1002002","EFO_0003060","EFO_0000311","EFO_0000537","Orphanet_98896","MONDO_0001134","MONDO_0100096","EFO_0002614","EFO_0004284","EFO_0001378","MONDO_0005148","EFO_0000181","HP_0030680","EFO_0000519"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 5 approved and 28 investigational indications."}
{"id":"CHEMBL78455","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"SAFPHFWYRLLBFO-NSOVKSMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL78455","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01678"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL815","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"PXGPLTODNUVGFL-YNNPMVKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINOPROST","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dinoprost","Pgf2a","Pgf2alpha","Prosmon","Prostaglandin f2-alpha","Prostaglandin f2.alpha.","Prostaglandin f2alpha","U-14,583","U-14583"],"crossReferences":{"PubChem":["144205330","29216066"],"Wikipedia":["Prostaglandin_F2alpha"],"drugbank":["DB12789"],"chEBI":["15553"]},"childChemblIds":["CHEMBL1200896"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
